FDA NDC Directory · JSON-LD · Markdown

Oxaliplatin

NDC 31722-358 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE

Labeler / ManufacturerCamber Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA217925
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsOXALIPLATIN (100 mg/20mL)
Marketing started20250127
Package count1

External sources

Source: openFDA. Public-domain (CC0).